ACN Newswire 營收利潤雙增長，寵物增長超10倍，朝雲集團完整財報出爐，被低估了？ HONG KONG, Apr 26, 2021 - (亞太商訊) - 4月23日，朝雲集團（6601.HK）發佈了上市後第一份完整財報，這也是新管理團隊到崗一年半後的首份完整財報。報告顯示，公司2020年實現營業收入人民幣 17.02億元，同比增長23%；年內溢利2.33億元，同比增長26.3%，經調整後增長達到32.4%，營收與淨利均取得雙位數增長，毛利率達44%，已經連續四年實現正增長。資料來源於年度報告資料來源於年度報告業務天花板足夠高，千億寵物市場將成為下一個風口作為中國領先的一站式多品類家居護理、寵物護理和個人護理平臺，連續多年在多個細分品類取得市場領導地位。據業績報告顯示，
ACN Newswire 營收利潤雙增長，寵物增長超10倍，朝雲集團完整財報出爐，被低估了？ HONG KONG, Apr 26, 2021 - (亞太商訊) - 4月23日，朝雲集團（6601.HK）發佈了上市後第一份完整財報，這也是新管理團隊到崗一年半後的首份完整財報。報告顯示，公司2020年實現營業收入人民幣 17.02億元，同比增長23%；年內溢利2.33億元，同比增長26.3%，經調整後增長達到32.4%，營收與淨利均取得雙位數增長，毛利率達44%，已經連續四年實現正增長。資料來源於年度報告資料來源於年度報告業務天花板足夠高，千億寵物市場將成為下一個風口作為中國領先的一站式多品類家居護理、寵物護理和個人護理平臺，連續多年在多個細分品類取得市場領導地位。據業績報告顯示，
ACN Newswire Starting its Industrial Investment in Biotech Companies, China Medical System (0867.HK) has Accelerated its Flywheel of Innovation HONG KONG, Apr 26, 2021 - (ACN Newswire) - China Medical System Holdings Limited (0867.HK) ("CMS" or the "Company") has been active in the market this year. From the acquisition of Luqa
ACN Newswire Sanofi Renews Partnership with Cielo to Strengthen its Talent Acquisition Strategy in Asia SINGAPORE, Apr 26, 2021 - (ACN Newswire) - Cielo, the world's leading Recruitment Process Outsourcing (RPO) provider, has renewed its partnership with Sanofi, a global biopharmaceutical company, to help them hire the best
ACN Newswire Daraz announces 2021 Seller Promises: Faster Pay-outs and Accelerated Business Growth for Local Entrepreneurs SINGAPORE, Apr 26, 2021 - (ACN Newswire) - Daraz, the leading e-commerce platform in South Asia, announced its commitment to providing additional support for local entrepreneurs and enhancing the selling experience on the
ACN Newswire Diplomatic Posturing and the Power Game in Southeast Asia Srinagar, Jammu and Kashmir, INDIA, Apr 26, 2021 - (ACN Newswire) - Dr Stephen R Nagy, in a recent interview by Mr Nadir Ali, Director of the Centre for Peace and Justice (JKCPJ)
ACN Newswire 泰諾麥博宣佈完成4.5億元人民幣A輪融資 HONG KONG, Apr 26, 2021 - (亞太商訊) - 近日，珠海泰諾麥博生物技術有限公司（Trinomab Biotech Co., Ltd. 簡稱“泰諾麥博”或“Trinomab”）宣佈完成4.5億元人民幣的A輪融資，此次融資由高瓴創投領投，康哲藥業、藥明生物產業基金、無錫國聯等共同參與完成。本輪融資款項主要用於：泰諾麥博天然全人源呼吸道合胞病毒單抗藥物TNM001、破傷風毒素單抗藥物TNM002以及神經生長因數單抗藥物TNM009的臨床研究；公司管線上其他天然全人源單克隆抗體藥物（如針對人巨細胞病毒、水痘-帶狀皰疹病毒、金黃色葡萄球菌α毒素及其它專案）的臨床前研究；以及2*
ACN Newswire 泰诺麦博宣布完成4.5亿元人民币A轮融资 HONG KONG, Apr 26, 2021 - (亚太商讯) - 近日，珠海泰诺麦博生物技术有限公司（Trinomab Biotech Co., Ltd. 简称“泰诺麦博”或“Trinomab”）宣布完成4.5亿元人民币的A轮融资，此次融资由高瓴创投领投，康哲药业、药明生物产业基金、无锡国联等共同参与完成。本轮融资款项主要用于：泰诺麦博天然全人源呼吸道合胞病毒单抗药物TNM001、破伤风毒素单抗药物TNM002以及神经生长因子单抗药物TNM009的临床研究；公司管线上其他天然全人源单克隆抗体药物（如针对人巨细胞病毒、水痘-带状疱疹病毒、金黄色葡萄球菌α毒素及其它项目）的临床前研究；以及2*
ACN Newswire UN youth envoy to open volunteer conference supporting Habitat for Humanity's COVID-19 response MANILA, Apr 23, 2021 - (ACN Newswire) - The United Nations Secretary-General's Envoy for Youth, Jayathma Wickramanayake, will deliver the opening remarks during the "Youth from Home for Homes" virtual conference, the peak
ACN Newswire 香港航天复牌股价暴涨逾650% 收购恒达科技 联手华为云 HONG KONG, Apr 23, 2021 - (亚太商讯) - 香港航天科技集团有限公司（香港航天）欣然宣布，已正式与香港华为云签订战略合作协议，双方将基于“数据创新生活 智慧开启城市”的合作目标，充分整合香港航天基于卫星端与地面端的时空城市信息，以及华为云安全、可信的数据处理能力，为粤港澳大湾区提供涵盖智慧政府、智慧出行、智慧生活、智慧环境等多维度的优质商业服务，打造全新的数码城市与智慧生活。香港航天董事局主席林家礼博士与华为香港代表处总经理邓水根主持战略合作签订仪式作为集卫星制造、卫星发射、航天测控及航天数据服务为一体的综合性商业航天企业，香港航天此次与华为云强强联手，将实现卫星遥感技术与云计算、大数据、人工智能等科技手段的结合，推动双方共同探索城市智慧化治理的新思路。借助华为云技术方案，
ACN Newswire 香港航天復牌股價暴漲逾650% 收購恆達科技 聯手華為雲 HONG KONG, Apr 23, 2021 - (亞太商訊) - 香港航天科技集團有限公司（香港航天）欣然宣佈，已正式與香港華為雲簽訂戰略合作協議，雙方將基於「數據創新生活 智慧開啟城市」的合作目標，充分整合香港航天基於衛星端與地面端的時空城市信息，以及華為雲安全、可信的數據處理能力，為粵港澳大灣區提供涵蓋智慧政府、智慧出行、智慧生活、智慧環境等多維度的優質商業服務，打造全新的數碼城市與智慧生活。香港航天董事局主席林家禮博士與華為香港代表處總經理鄧水根主持戰略合作簽訂儀式作爲集衛星製造、衛星發射、航天測控及航天數據服務為一體的綜合性商業航天企業，香港航天此次與華為雲强强聯手，將實現衛星遙感技術與雲計算、大數據、人工智能等科技手段的結合，推動雙方共同探索城市智慧化治理的新思路。借助華爲雲技術方案，
ACN Newswire Annual Report on Form 20-F for Fiscal Year 2020 of Aluminum Corporation of China Limited Now Available BEIJING, Apr 23, 2021 - (ACN Newswire) - Aluminum Corporation of China Limited (the "Company"; NYSE "ACH"; SEHK "2600"; SSE "601600") announces that the Company's annual report for the 2020 fiscal year filed
ACN Newswire Central Global Berhad's Proposed Private Placement Approved by Bursa Securities KUALA LUMPUR, Apr 23, 2021 - (ACN Newswire) - Central Global Berhad's ("CGB") proposed private placement of up to 18 million new ordinary shares has been approved by Bursa Malaysia Securities Berhad ("Bursa
ACN Newswire Avance Clinical受邀发表“分散试验–不再回头” 适用于Oracle Health Sciences Connect ADELAIDE, AU, Apr 23, 2021 - (亚太商讯) - 澳大利亚领先的生物技术CRO和Frost＆Sullivan亚太CRO市场领导奖获得者Avance Clinical已应邀在Oracle Health Sciences Connect会议上介绍了分散临床试验的未来。标题：分散试验-不再回头链接：www.oracle.com/in/industries/life-sciences/health-sciences-connect/sessions/时间：2021年4月23日–下午3.05（澳大利亚/阿德莱德ACST）。Avance Clinical首席执行官Yvonne Lungershausen分享了公司对非集中化临床试验（
ACN Newswire Avance Clinical受邀發表“分散試驗–不再回頭” 適用於Oracle Health Sciences Connect ADELAIDE, AU, Apr 23, 2021 - (亞太商訊) - 澳大利亞領先的生物技術CRO和Frost＆Sullivan亞太CRO市場領導獎獲得者Avance Clinical已應邀在Oracle Health Sciences Connect會議上介紹了分散臨床試驗的未來。標題：分散試驗-不再回頭鏈接：www.oracle.com/in/industries/life-sciences/health-sciences-connect/sessions/時間：2021年4月23日–下午3.05（澳大利亞/阿德萊德ACST）。Avance Clinical首席執行官Yvonne Lungershausen分享了公司對非集中化臨床試驗（
ACN Newswire Tim Da Jeweler Announces His Remarkable Custom Hats Laced With Hand Set Diamonds Oakland, CA, Apr 23, 2021 - (ACN Newswire) - Trailblazer custom Jewelry designer Tim Da Jeweler is elevating his creativity and design skills with the release of his breathtaking custom hat composed of
ACN Newswire 中滙集團2021財年中期業績超預期 HONG KONG, Apr 23, 2021 - (亞太商訊) - 粵港澳大灣區（「大灣區」）最大的民辦商科高等教育集團中滙集團控股有限公司（「中滙集團」或「本集團」，股票編號：0382.HK）欣然公佈截至2021年2月28日止六個月（「報告期」）未經審計之2021財年中期業績。上海主會場 上海浦東麗思卡爾頓大酒店，左起：首席運營官 劉文琦女士；執行董事兼首席執行官 廖伊曼女士香港會場 中滙集團香港辦公室，左起：投融資及投資者關係部總監 印國庭先生；創辦人及執行董事兼董事會主席 廖榕就先生；
ACN Newswire Moonstake, 신뢰받는 랭킹 플랫폼인 Staking Rewards의 CEO Mirkos Schmiedl과의 공동 인터뷰 개최 SINGAPORE, Apr 23, 2021 - (ACN Newswire) - 올해 4월 1주년을 기념하기 위해 문스테이크는 스테이킹 및 수익률이 있는 자산 데이터를 위한 마켓에서 가장 신뢰할 수 있는 리소스 허브인 Staking Rewards와 공동 Q&
ACN Newswire Moonstake Hosts Joint Interview with CEO of Trusted Ranking Platform Staking Rewards, Mirkos Schmiedl SINGAPORE, Apr 23, 2021 - (ACN Newswire) - To celebrate our first anniversary this April, Moonstake held a joint Q&A with Staking Rewards, the first and most trusted resource hub for
ACN Newswire Pertama Digital expresses interest to apply for BNM's digital banking license, currently in talks to form dedicated consortium SELANGOR, Malaysia, Apr 23, 2021 - (ACN Newswire) - Pertama Digital Berhad (PERTAMA), a Bursa Malaysia Main Market listed investment holding company in the government technology and fintech spaces, today announced its digital
ACN Newswire 华领医药糖尿病首创新药多扎格列艾汀NDA获NMPA受理！为全球首个葡萄糖激酶激活剂 SHANGHAI, CHINA, Apr 23, 2021 - (亚太商讯) - 华领医药（「公司」，香港联交所股份代号：2552.HK），今天宣布，糖尿病首创新药多扎格列艾汀( dorzagliatin)递交的NDA申请已获国家药品监督管理局（NMPA）新药审评中心（CDE）受理。多扎格列艾汀成为全球范围内首个提交新药上市申请的葡萄糖激酶激活剂类（GKA）糖尿病治疗药物，并有望成为在中国首先上市的全球首创新药（FIC）。独创「修复传感，重塑稳态，从源头上治疗糖尿病」的科学理念，华领医药自成立以来就始终关注临床上尚未被满足的需求，致力于通过开发具有颠覆性理念的突破性产品，
ACN Newswire 華領醫藥糖尿病首創新藥多扎格列艾汀NDA獲NMPA受理！為全球首個葡萄糖激酶激活劑 SHANGHAI, CHINA, Apr 23, 2021 - (亞太商訊) - 華領醫藥（「公司」，香港聯交所股份代號：2552.HK），今天宣布，糖尿病首創新藥多扎格列艾汀(dorzagliatin)遞交的NDA申請已獲國家藥品監督管理局（NMPA）新藥審評中心（CDE）受理。多扎格列艾汀成為全球範圍內首個提交新藥上市申請的葡萄糖激酶激活劑類（GKA）糖尿病治療藥物，並有望成為在中國首先上市的全球首創新藥（FIC）。獨創「修復傳感，重塑穩態，從源頭上治療糖尿病」的科學理念，華領醫藥自成立以來就始終關注臨床上尚未被滿足的需求，致力於通過開發具有顛覆性理念的突破性產品，
ACN Newswire Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally SHANGHAI, CHINA, Apr 23, 2021 - (ACN Newswire) - Hua Medicine (the "Company", Stock Code: 2552.HK), today announced that the New Drug Application (NDA) for dorzagliatin for the treatment of Type 2
ACN Newswire 아방스 클리니컬, 오라클 헬스 사이언스 커넥트에 초청되어 "분산형 실험 - 이전으로 돌아갈 수 없는 획기적 발전" 발표 ADELAIDE, AU, Apr 23, 2021 - (ACN Newswire) - 호주의 바이오테크 임상수탁기관(CRO)선두주자이자 프로스트&설리번(Frost & Sullivan)이 수여하는 아시아태평양 CRO 마켓 리더십 어워드(Asia-Pacific CRO Market Leadership Award)를
ACN Newswire Avance Clinical Invited to Present "Decentralized Trials - No Going Back" for Oracle Health Sciences Connect ADELAIDE, AU, Apr 22, 2021 - (ACN Newswire) - The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on
